Edward J. Fox
CDG Therapeutics (United States)(US)Tenax Therapeutics (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Advanced Proteomics Techniques and Applications, S100 Proteins and Annexins, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → The basis of cellular and regional vulnerability in Alzheimer’s disease(2019)150 cited
- → Mapping medically relevant RNA isoform diversity in the aged human frontal cortex with deep long-read RNA-seq(2024)47 cited
- → Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity(2024)37 cited
- → Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid(2024)35 cited
- → Brain proteomic analysis implicates actin filament processes and injury response in resilience to Alzheimer’s disease(2023)34 cited
- → Single-synapse analyses of Alzheimer’s disease implicate pathologic tau, DJ1, CD47, and ApoE(2021)31 cited
- → Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations(2024)20 cited
- → Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease(2024)17 cited
- → Global analysis of the heparin-enriched plasma proteome captures matrisome-associated proteins in Alzheimer’s disease(2023)14 cited
- → Using deep long-read RNAseq in Alzheimer’s disease brain to assess medical relevance of RNA isoform diversity(2023)14 cited